Production (Stage)
Fennec Pharmaceuticals Inc.
FENC
$7.93
-$0.39-4.69%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -55.70% | 100.72% | 225.19% | 187.83% | 178.33% |
Total Receivables | 50.36% | 46.18% | 185.26% | 403.56% | 510.46% |
Inventory | -31.98% | -50.83% | -35.90% | 48.99% | 124.84% |
Prepaid Expenses | -45.54% | 19.61% | 1,141.30% | 858.21% | 602.35% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 523.60% | 959.09% | 2,630.00% | 784.38% | 403.13% |
Total Current Assets | -36.96% | 64.29% | 205.95% | 221.62% | 214.70% |
|
|||||
Total Current Assets | -36.96% | 64.29% | 205.95% | 221.62% | 214.70% |
Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 235.42% | 13,600.00% | 1,703.77% | 833.02% | 542.77% |
Total Assets | -32.94% | 67.31% | 209.65% | 224.95% | 217.09% |
|
|||||
Total Accounts Payable | 1.46% | -14.21% | 31.49% | 47.99% | 76.59% |
Total Accrued Expenses | -34.84% | -8.68% | 248.37% | 293.01% | 306.62% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -90.48% | -66.67% | -- | -- |
Total Finance Division Other Current Liabilities | -1.59% | -- | -- | -- | -- |
Total Other Current Liabilities | -1.59% | -- | -- | -- | -- |
Total Current Liabilities | -14.89% | -8.39% | 90.01% | 105.11% | 144.68% |
|
|||||
Total Current Liabilities | -14.89% | -8.39% | 90.01% | 105.11% | 144.68% |
Long-Term Debt | -38.27% | -37.48% | 25.18% | 25.17% | 24.70% |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -1.73% | 1,227,950.00% | -- | -- | -- |
Total Liabilities | -21.00% | 32.04% | 116.83% | 121.22% | 126.95% |
|
|||||
Common Stock & APIC | 2.66% | 3.00% | 3.17% | 2.77% | 3.74% |
Retained Earnings | -6.99% | -0.20% | -0.52% | 1.27% | 1.36% |
Treasury Stock & Other | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Common Equity | -295.09% | 49.48% | 50.90% | 86.05% | 141.07% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -295.09% | 49.48% | 50.90% | 86.05% | 141.07% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -295.09% | 49.48% | 50.90% | 86.05% | 141.07% |
|